Dr Ettienne Lugo Delgado, OD in Camuy, PR - Medicare Provider

Dr Ettienne Lugo Delgado, OD is a medicare enrolled "Optometrist" provider in Camuy, Puerto Rico. His current practice location is Calle Luis Munoz Rivera 5, Suite 2, Camuy, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 262-1486.

Dr Ettienne Lugo Delgado is licensed to practice in Puerto Rico (license number 573) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1982669750.

Contact Information

	Dr Ettienne Lugo Delgado, OD
	Calle Luis Munoz Rivera 5, Suite 2, Camuy, PR 00627-0000
	(787) 262-1486
	(787) 262-1486

Healthcare Provider's Profile

Full Name	Dr Ettienne Lugo Delgado
Gender	Male
Speciality
Experience	Years
Location	Calle Luis Munoz Rivera 5, Camuy, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Ettienne Lugo Delgado attended and graduated from in

NPI Data:

NPI Number: 1982669750
Provider Enumeration Date: 04/17/2006
Last Update Date: 10/09/2012

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Ettienne Lugo Delgado such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1982669750	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	573 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ettienne Lugo Delgado is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ettienne Lugo Delgado, OD 4 Calle Hollywood Drive, Urb. Hollywood Estates, San Juan, PR 00926 Ph: (787) 262-1486	Dr Ettienne Lugo Delgado, OD Calle Luis Munoz Rivera 5, Suite 2, Camuy, PR 00627-0000 Ph: (787) 262-1486

News Archive

Perrigo Company acquires basket of value-brand OTC products in Australia

Perrigo Company plc announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc. for $51 million in cash.

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

FDA announces label changes for Regranex - boxed warning

The U.S. Food and Drug Administration has announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product. Regranex is a topical cream indicated for the treatment of leg and foot ulcers that are not healing in diabetic patients.

FDA accepts proposed proprietary name Exelbine for ADVENTRX Pharmaceuticals' ANX-530

ADVENTRX Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the proposed proprietary name "Exelbine™" for the Company's product candidate ANX-530 (vinorelbine injectable emulsion).

Optometrist in Camuy, PR

Andres Rivera, OD Optometrist Medicare: Medicare Enrolled Practice Location: Calle Iguina #3, Tu Centro De Vision Integral, Camuy, PR 00627 Phone: 787-820-4622 Fax: 787-820-4622
Andres Rivera Pacheco Optometrist Medicare: Not Enrolled in Medicare Practice Location: Calle Iguina, # 3, Camuy, PR 00627 Phone: 787-820-4622 Fax: 787-820-4622
Clinica Visual Del Noroeste Corp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 Hacienda Terra Linda, Camuy, PR 00627 Phone: 787-930-3387
Dba Accu Vision Optometrist Medicare: Not Enrolled in Medicare Practice Location: Calle Luis Munoz Rivera 5, Camuy, PR 00627 Phone: 787-262-1486 Fax: 787-262-1486

Dr Ettienne Lugo Delgado, OD - Medicare Optometrist in Camuy, PR